Kraig Biocraft Laboratories Inc (KBLB)

[TRUISM]

Kraig Biocraft Laboratories Develops New Breakthrough Spider Silk DNA Synthesis Protocols Accelerating Time To Market For New Products
May 23, 2018
Click For Today's PR





Kraig Labs’ R&D team raises the bar in transgenic research



ANN ARBOR, Mich., – May 23, 2018 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its R&D team has achieved a major breakthrough in the construction of DNA encoding for spider silk proteins.

With this new capability the Company believes that it should be able to reduce the customization timeframe, for new spider silk technologies, by several months.

The new protocols were developed after Kraig Labs reached out to leading DNA synthesis facilities, which all stated that construction of the desired sequences would be practically impossible, due to the unique structure of spider silk proteins. Refusing to accept that answer, Kraig’s research team then took on the task directly.

Using a combination of distinct approaches, Kraig Labs successfully synthesized the highly complex set of spider silk protein construct designs. This new approach should accelerate the pace of its research and production rollout efforts, as well as reduce costs to develop new transgenics for new potential markets and applications.

The newly designed protein constructs are currently being prepared for incorporation into the Company’s spider silk platform technology. Due to their construction, these new designs may have the potential to produce new silk fibers with even greater strength and flexibility than the Company’s current generation of recombinant spider silk.

“Today’s announcement is another in a long history of Kraig Labs proving the impossible, possible,” said Jon Rice, COO. “From our first transgenic silkworms, to the creation of Monster Silk and then Dragon Silk, to obtaining approvals for international expansion, the Company has proven, time and time again, that we have the tenacity to reimagine what is possible.

These new constructs and the ability to rapidly adapt them could open new and wider applications in military and high performance technical textile markets. Today we celebrate yet another example of how the Company is changing the rules in biotech development.”




Blessings to All

TRUTH